posting velocity //
Opens vs closes per day
Based on 0 events over 90 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
Posting timing (day/hour) is available only when there are at least 5 jobs with a real publish stamp spread across 3 distinct days. This company's source doesn't expose post times, or there isn't enough data yet — showing what we know for sure: how many jobs are open, in which domains, and at which seniority levels.
Showing: Israel. Click another pill to switch.
Open now
0
Total active openings across all sites
Δ 28-day
0
Opens minus closes in the last 28 days
Δ 90-day
0
Opens minus closes in the last 90 days
posting velocity //
Based on 0 events over 90 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
role mix //
—
The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.
seniority pyramid //
Seniority is not exposed by the source for this company.
Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.
geography //
—
Active openings by region. Click a row to see jobs in that area.
time on market //
Median
—
25th pct
—
75th pct
—
—
Based on 0 closed jobs and 0 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.
Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.
Republish rate
—
Fewer than 10 closures in the window — not enough to compute.
company intel · ai-generated
Updated 1d ago
Bayer is a German life sciences company founded in 1863 in Barmen (now part of Wuppertal), Germany. Its global headquarters are located in Leverkusen, Germany. The company is listed on the Frankfurt Stock Exchange under the ticker BAYN and is a constituent of the DAX index. Bayer operates through three main divisions: Pharmaceuticals, Consumer Health, and Crop Science.
Bayer's Pharmaceuticals division focuses on prescription medicines, most notably Xarelto (rivaroxaban) — a blood thinner that was one of the company's flagship revenue drivers — and Eylea (aflibercept) for the treatment of eye diseases. The Crop Science division, significantly enlarged after the acquisition of Monsanto, encompasses seeds, herbicides, and agricultural products. The Consumer Health division markets over-the-counter health products including Aspirin and Claritin.
Xarelto is an anticoagulant approved across multiple indications and served as a primary growth engine for the Pharmaceuticals segment. Eylea, commercialized in partnership with Regeneron, is used to treat age-related macular degeneration and other ophthalmic conditions. Within Crop Science, the Roundup and Roundup Ready brands — acquired through the Monsanto deal — have been at the center of extensive litigation over alleged glyphosate-related harms.
Bayer's direct competitors in pharmaceuticals include Novartis, Pfizer, and Johnson & Johnson. In Crop Science, the primary rivals are Syngenta, Corteva, and BASF. The acquisition of Monsanto in 2018 for approximately $63 billion made Bayer one of the largest agricultural companies globally, but also brought thousands of glyphosate-related lawsuits that weighed heavily on the company's market capitalization in subsequent years.
Detailed public information about Bayer's Israeli operations is limited. The company maintains a commercial presence in Israel, primarily focused on marketing pharmaceuticals and Consumer Health products, but I cannot confirm with confidence the specific office locations, local headcount, or whether any R&D function operates in Israel.
key people & leadership
1 key people, sourced from public records — with a per-row confidence score.
Bill Anderson
Chief Executive Officer
news feed
No recent news about this company.